Back
SNX14HGNC ARPubMedFunctional SNV

A Homozygous Deep Intronic SNX14 Variant Activates Pseudo-Exon Inclusion in a Patient with SCAR20

Misceo D, Strømme P, Sundaram AYM, et al.Genes (Basel), 2026 · March 2026
Relevance score
8/10
Disease / domain
SCAR20 (autosomal recessive spinocerebellar ataxia type 20)
Source
PubMed
PMID 42074495
Share on LinkedIn

Variant / mechanism

SNX14 (homozygous deep intronic variant)

Homozygous deep intronic SNX14 variant → pseudo-exon inclusion → intronic sequence inserted in mRNA → loss of function; undetectable by exome alone, requires WGS

Summary

Identification of a homozygous deep intronic SNX14 variant as the cause of SCAR20 in a patient with a negative exome. The variant activates pseudo-exon inclusion in SNX14 mRNA, leading to loss of function. This case illustrates the underestimation of deep intronic variants in the etiology of Mendelian diseases: they contribute to the differential diagnostic yield of WGS over exome, estimated at 2-15% across cohorts. Functional validation by RNA-seq confirms the transcriptional impact.

Synthesis written by Geno'X. For the full original abstract, please refer to the source publication.

Analysis

This case strengthens the argument for first-tier WGS in recessive cerebellar ataxias unresolved after exome. SNX14 is the causal gene for SCAR20 — a syndrome of ataxia + psychomotor delay + distinctive facies — and deep intronic variants in this gene should not be overlooked in secondary WGS interpretation.

Why this score?

exemplary deep intronic mechanism +3; biallelic AR +2; diagnostic yield impact WGS vs exome +2; Genes (MDPI) +1

Keywords

SNX14SCAR20deep intronicpseudo-exonrecessive ataxiaWGS
Weekly report in your inbox

Every Wednesday · Annotated selection · Free · Unsubscribe anytime